Trials / Completed
CompletedNCT00032942
Lofexidine for Opiate Withdrawal - 1
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 66 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate lofexidine for opiate withdrawal.
Detailed description
An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment seeking individuals randomized to 2 medication groups: lofexidine and placebo to be conducted in inpatient units at 3 treatment sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lofexidine |
Timeline
- Start date
- 2001-04-01
- Primary completion
- 2004-10-01
- First posted
- 2002-04-08
- Last updated
- 2017-01-12
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00032942. Inclusion in this directory is not an endorsement.